Asymmetric synthesis of (R)-N-3-butyn-2-yl-N-hydroxyurea, a key intermediate for 5-lipoxygenase inhibitors

Tetrahedron Asymmetry

Volumn 7, Issue 3, 1996, Pages 729-736

  Kolasa, Teodozyj ^a   Stewart, Andrew O ^a   Brooks, Clint D W ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA DERIVATIVE; LIPOXYGENASE INHIBITOR; N (3 BUTYN 2 YL) N HYDROXYUREA; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; ENANTIOMER; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; REACTION ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 0029870741     PISSN: 09574166     EISSN: None     Source Type: Journal    
DOI: 10.1016/0957-4166(96)00068-7     Document Type: Article

References (23)

1. a) Israel, E. Ann. Allergy 1994, 72, 279.
2. b) Brooks, D. W. Expert Opin. Invest. Drugs 1994, 3, 185.
3. a) Brooks, D. W., Carter, G. W. The Discovery of Zileuton. In The Search for Anit-Inflammatory Drugs, Merluzzi, V., Adams, J., Eds.; Birkhäuser: Boston, 1995; p. 129.
4. b) Carter, G. W.; Young, P. R.; Albert, D. H.; Bouska, J.; Dyer, R.; Bell, R. L.; Summers, J. B.; Brooks, D. W. J. Pharmacol. Exp. Ther. 1991, 256, 929.
5. (a) Israel, E.; Rubin, P.; Kemp, J. P.; Grossman, J.; Pierson, W.; Siegel, S. C.; Tinkelman, D.; Murray, J. J.; Busse, W.; Segal, A. T.; Fish, J.; Kaiser, H. B.; Ledford, D.; Wenzel, S.; Rosenthal, R.; Cohn, J.; Lanni, C.; Pearlman, H.; Karahalios, P.; Drazen, J. M. Ann. Intern. Med. 1993, 119, 1059.
6. (b) Israel, E.; Dermarkarian, R.; Rosenberg, M.; Sperling, R.; Taylor, G.; Rubin, P.; Drazen, J. M. N. Engl. J. Med. 1990, 323, 1740.
7. (c) Israel, E.; Fischer, A. R.; Rosenberg, M. W.; Lilly, C. M.; Callery, J. C.; Shapiro, J.; Cohn, J.; Rubin, P.; Drazen, J. M. Am. Rev. Respir. Dis. 1993, 148, 1447.
8. a) Brooks, D. W.; Summers, J. B.; Stewart, A. O.; Bell, R. L.; Bouska, J.; Lanni, C.; Young P. R.; Rubin, P.; Carter, G. W. Novel Inhibitors of Leukotriene Biosynthesis. In Perspectives in Medicinal Chemistry ; Testa, B., Kyburz, E., Fuhrer, W., Giger, R. Eds.; Verlag: Basel, 1993; p. 119.
9. b) Bell, R. L.; Bouska, J. B.; Malo, P. E.; C. Lanni, C.; Harris, R. R.; Otis, E.R.; Stewart, A. O.; Brooks, D. W.; Carter, G. W. J. Pharm. Exp. Therapeut. 1995, 272, 724.
10. Carter, G. W.; Bell, R. L.; Marsh, K.; Lanni, C; Awni, W. M.; Bouska, J.; Stewart, A.O., Hansen, R.; Dubé, L.; Brooks, D. W. In Cellular Generation, Transport, and Effects of Eicosanoids, Annals N.Y. Ac. Sci., 1994, 744, 262.
11. Mitsunobu, O. Synthesis 1981, 1.
12. Stewart, A. O.; Brooks, D. W. J. Org. Chem. 1992, 57, 5020.
13. a) Midland, M. M. Chem. Rev. 1989, 59, 1553.
14. b) Midland, M. M.; McDowell, D. C.; Hatch, R. L.; Tramontano, A. J. Am. Chem. Soc. 1980, 702, 867.
15. De Amici, M.; De Micheli, C; Carrea, G; Spezia, S. J Org. Chem. 1989, 54, 2646.
16. Al-Kassim, L.; Tsai, C. S. Biochem. Cell Biol. 1990, 68, 907.
17. Dale, J. A.; Dull, L. D.; Mosher, H. S. J. Org. Chem. 1969, 34, 2543.
18. Huges, D. L. Organic Reactions Paquette, et. al., Eds.; John Wiley & Sons, Inc. : 1992; Chapter 2; p. 335.
19. Dieck, H. A.; Heck, R. F. J. Organomet. Chem. 1975, 93, 259.
20. Ku, Y.-Y.; Patel, R. P.; Elisseou, E. M.; Sawick, D.P. Tetrahedron Lett. 1995, 36, 2733
21. Gao, Y.; Hanson, R. M.; Klunder, J. M.; Ko, S. Y.; Masamune, H.; Sharpless, K. B. J. Am. Chem. Soc. 1987, 109, 5765.
22. a). Brooks, D. W.; Stewart, A. O.; Basha, A.; Bhatia, P.; Ratajczyk, J. D. U. S. Patent 5,288,751, Feb. 22, 1994.
23. b) Brooks, C. D. W.; Stewart, A. O.; Basha, A.; Bhatia, P.; Ratajczyk, J. D.; Martin, J. G.; Craig, R. A.; Kolasa, T.; Bouska, J. B.; Lanni, C.; Harris, R. R.; Malo, P. E.; Carter, G. W.; Bell, R. L. J. Med. Chem. in press.